Recently Updated NPI Information — some details in this NPI profile have been updated in the NPI registry within the last 60 days.

MRS. KELLY RAE LONDON PA-C
Prescription History 1255595708
Physician Assistant in Baltimore, MD

Active since July 14, 2008PECOS EnrolledAccepts Medicare Assignment
9103 FRANKLIN SQUARE DR STE 305, BALTIMORE, MD 21237(443) 777-7608(443) 777-8218 Get Directions

NPPES record last updated: September 22, 2026. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MRS. KELLY RAE LONDON PA-C, an active Physician Assistant specialist practicing in Baltimore, MD. Our medical registry currently tracks 13 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 546 documented patient claims. Among these therapy options, the most frequently utilized medication is Gemtesa, which accounts for 110 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

13
Medications
546
Total Claims
1,059
30-Day Fills
Gemtesa
Most Prescribed · 110 claims
View details
13 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by MRS. KELLY RAE LONDON PA-C in 2024, with prescription volumes, average cost per fill, and MD state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other MD PrescribersVs. MD Avg

About Gemtesa: This medication is used to treat overactive bladder. Show more ▾

Overactive bladder is a problem with how your bladder stores urine that causes a sudden urge to urinate. The urge may be hard to control, and overactive bladder symptoms may include frequent urination, strong sudden urges to urinate, or involuntary loss of urine (incontinence). Vibegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder. A beta3 adrenergic receptor agonist.

In 2024, this provider wrote 110 Medicare prescriptions for Gemtesa, about 2 times the volume of the typical Maryland prescriber of this medication (54.9). Medicare paid an average of $1,104.65 per fill, versus $852.15 statewide.

How often this provider prescribes it

This provider
110
MD average
54.9

This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,104.65
MD average
$852.15

Gross Part D cost per fill; not the patient's out-of-pocket price.

255.5
30-Day Fills
standardized to 30-day supplies
7,648
Days of Medication
total across all patients in 2024

About Tamsulosin Hcl: Tamsulosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾

It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Tamsulosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. A sulfonamide derivative and adrenergic alpha-1 receptor antagonist that is used to relieve symptoms of urinary obstruction caused by BENIGN PROSTATIC HYPERPLASIA.

In 2024, this provider wrote 77 Medicare prescriptions for Tamsulosin Hcl, about the same volume as the typical Maryland prescriber of this medication (70.7). Medicare paid an average of $16.07 per fill, versus $18.03 statewide.

How often this provider prescribes it

This provider
77
MD average
70.7

This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$16.07
MD average
$18.03

This provider's average cost per fill is below the MD average for this medication.

179
30-Day Fills
standardized to 30-day supplies
5,323
Days of Medication
total across all patients in 2024

About Cefdinir: Cefdinir is used to treat a wide variety of bacterial infections. Show more ▾

This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A third-generation oral cephalosporin antibacterial agent that is used to treat bacterial infections of the respiratory tract and skin.

In 2024, this provider wrote 61 Medicare prescriptions for Cefdinir, about 2.6 times the volume of the typical Maryland prescriber of this medication (23.8). Medicare paid an average of $12.07 per fill, versus $15.47 statewide.

How often this provider prescribes it

This provider
61
MD average
23.8

This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$12.07
MD average
$15.47

This provider's average cost per fill is below the MD average for this medication.

61
30-Day Fills
standardized to 30-day supplies
424
Days of Medication
total across all patients in 2024

About Solifenacin Succinate: Solifenacin is used to treat an overactive bladder. Show more ▾

By relaxing the muscles in the bladder, solifenacin improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics. A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE.

In 2024, this provider wrote 61 Medicare prescriptions for Solifenacin Succinate, about 2 times the volume of the typical Maryland prescriber of this medication (30.3). Medicare paid an average of $45.08 per fill, versus $52.05 statewide.

How often this provider prescribes it

This provider
61
MD average
30.3

This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$45.08
MD average
$52.05

This provider's average cost per fill is below the MD average for this medication.

116.4
30-Day Fills
standardized to 30-day supplies
3,450
Days of Medication
total across all patients in 2024

About Myrbetriq: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾

Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). Mirabegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder and neurogenic detrusor overactivity. A beta3-adrenergic receptor agonist.

In 2024, this provider wrote 50 Medicare prescriptions for Myrbetriq, about 1.3 times the volume of the typical Maryland prescriber of this medication (39). Medicare paid an average of $1,045.47 per fill, versus $701.44 statewide.

How often this provider prescribes it

This provider
50
MD average
39.0

This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,045.47
MD average
$701.44

Gross Part D cost per fill; not the patient's out-of-pocket price.

120
30-Day Fills
standardized to 30-day supplies
3,600
Days of Medication
total across all patients in 2024

About Estradiol: This medication is a hormone. Show more ▾

It is used by women to help reduce vaginal symptoms of menopause (such as vaginal dryness/burning/itching). These symptoms are caused by the body making less estrogen. When treating only vaginal symptoms of menopause, products applied directly inside the vagina (such as this medication) should be used first. Estrogens that are taken by mouth, absorbed through the skin, or injected may have greater risks of side effects due to more estrogen being absorbed. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.

In 2024, this provider wrote 36 Medicare prescriptions for Estradiol, about the same volume as the typical Maryland prescriber of this medication (38.9). Medicare paid an average of $63.70 per fill, versus $71.62 statewide.

How often this provider prescribes it

This provider
36
MD average
38.9

This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$63.70
MD average
$71.62

This provider's average cost per fill is below the MD average for this medication.

90.6
30-Day Fills
standardized to 30-day supplies
2,689
Days of Medication
total across all patients in 2024

About Nitrofurantoin: This medication is used to treat or prevent certain urinary tract infections. Show more ▾

This medication is an antibiotic that works by stopping the growth of bacteria. It will not work for viral infections (such as common cold, flu). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. Nitrofurantoin should not be used by children less than one month of age due to the risk of a certain blood problem (hemolytic anemia). A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression.

In 2024, this provider wrote 30 Medicare prescriptions for Nitrofurantoin, about the same volume as the typical Maryland prescriber of this medication (26.3). Medicare paid an average of $23.74 per fill, versus $32.29 statewide.

How often this provider prescribes it

This provider
30
MD average
26.3

This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$23.74
MD average
$32.29

This provider's average cost per fill is below the MD average for this medication.

45
30-Day Fills
standardized to 30-day supplies
926
Days of Medication
total across all patients in 2024

About Methenamine Hippurate: Methenamine is used to prevent or control returning urinary tract infections caused by certain bacteria. Show more ▾

It is not used to treat an active infection. Antibiotics must be used first to treat and cure the infection. Methenamine is a drug that stops the growth of bacteria in urine. This medication also contains an ingredient that helps to make the urine acidic. When the urine is acidic, methenamine turns into formaldehyde to kill the bacteria. This drug is effective only against bacterial infections in the urinary tract. It will not work for other types of bacterial infections (such as in the blood) or for viral infections (such as the common cold or flu). Unnecessary use or misuse of any antibacterial drug can lead to its decreased effectiveness. Both parts of molecule contribute to its antibacterial action.

In 2024, this provider wrote 29 Medicare prescriptions for Methenamine Hippurate, about 85% of the volume of the typical Maryland prescriber of this medication (34.3). Medicare paid an average of $82.79 per fill, versus $72.15 statewide.

How often this provider prescribes it

This provider
29
MD average
34.3

This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$82.79
MD average
$72.15

Gross Part D cost per fill; not the patient's out-of-pocket price.

41
30-Day Fills
standardized to 30-day supplies
1,208
Days of Medication
total across all patients in 2024

About Oxybutynin Chloride Er: This is a long-acting form of oxybutynin that is used to treat overactive bladder and urinary conditions. Show more ▾

It relaxes the muscles in the bladder to help decrease problems of urgency and frequent urination. Oxybutynin belongs to a class of drugs known as antispasmodics. This medication is also used to treat children 6 years of age and older who have an overactive bladder due to certain nerve disorders (such as spina bifida).

In 2024, this provider wrote 29 Medicare prescriptions for Oxybutynin Chloride Er, about the same volume as the typical Maryland prescriber of this medication (29.7). Medicare paid an average of $20.58 per fill, versus $26.31 statewide.

How often this provider prescribes it

This provider
29
MD average
29.7

This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$20.58
MD average
$26.31

This provider's average cost per fill is below the MD average for this medication.

81
30-Day Fills
standardized to 30-day supplies
2,400
Days of Medication
total across all patients in 2024

About Ciprofloxacin Hcl: This medication is used to treat a variety of bacterial infections. Show more ▾

Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A broad-spectrum antimicrobial carboxyfluoroquinoline.

In 2024, this provider wrote 23 Medicare prescriptions for Ciprofloxacin Hcl, about 88% of the volume of the typical Maryland prescriber of this medication (26.2). Medicare paid an average of $3.33 per fill, versus $6.34 statewide.

How often this provider prescribes it

This provider
23
MD average
26.2

This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$3.33
MD average
$6.34

This provider's average cost per fill is below the MD average for this medication.

23
30-Day Fills
standardized to 30-day supplies
118
Days of Medication
total across all patients in 2024

About Nitrofurantoin Mono-Macro: This medication is an antibiotic used to treat bladder infections (acute cystitis). Show more ▾

It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. This medication should not be used in infants younger than 1 month old (see also Precautions section). This drug should not be used to treat infections outside the bladder (including kidney infections such as pyelonephritis or perinephric abscesses).

In 2024, this provider wrote 18 Medicare prescriptions for Nitrofurantoin Mono-Macro, about 75% of the volume of the typical Maryland prescriber of this medication (24). Medicare paid an average of $12.52 per fill, versus $13.95 statewide.

How often this provider prescribes it

This provider
18
MD average
24.0

This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$12.52
MD average
$13.95

This provider's average cost per fill is below the MD average for this medication.

24
30-Day Fills
standardized to 30-day supplies
374
Days of Medication
total across all patients in 2024

About Exelon: Rivastigmine is used to treat confusion (dementia) related to Alzheimer's disease and to Parkinson's disease. Show more ▾

Rivastigmine does not cure either of these diseases, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by restoring the balance of natural substances (neurotransmitters) in the brain. A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.

In 2024, this provider wrote 11 Medicare prescriptions for Exelon, about 70% of the volume of the typical Maryland prescriber of this medication (15.6). Medicare paid an average of $728.08 per fill, versus $657.96 statewide.

How often this provider prescribes it

This provider
11
MD average
15.6

This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$728.08
MD average
$657.96

Gross Part D cost per fill; not the patient's out-of-pocket price.

11
30-Day Fills
standardized to 30-day supplies
330
Days of Medication
total across all patients in 2024

About Memantine Hcl: Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. Show more ▾

It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease. AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent.

In 2024, this provider wrote 11 Medicare prescriptions for Memantine Hcl, about a quarter of the volume of the typical Maryland prescriber of this medication (50.8). Medicare paid an average of $62.01 per fill, versus $36.74 statewide.

How often this provider prescribes it

This provider
11
MD average
50.8

This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$62.01
MD average
$36.74

Gross Part D cost per fill; not the patient's out-of-pocket price.

11.2
30-Day Fills
standardized to 30-day supplies
334
Days of Medication
total across all patients in 2024
No medications match the current filters.
= the 5 medications this provider prescribes most.▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average MD prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the MD average cost per fill.

About this data. The prescription history for MRS. KELLY RAE LONDON PA-C is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Physician Assistant prescribing approach at this Baltimore, MD practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MD prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.